Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Carcinoma

Explore clinical trials studying Neuroendocrine Carcinoma. Study availability and eligibility vary by location and protocol.

52 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Carcinoma trial results

Active, not recruiting

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT04471727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, not recruiting

A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3

NCT04524208

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
Locations
  • Medizinische Universität Wien Vienna, Austria
  • University Medical Center Göttingen Göttingen, Lower Saxony, Germany
  • Zentralklinik Bad Berka GmbH Bad Berka, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden, Germany
View all 15 locations
View Trial Details
Completed

Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT01642251

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
View all 428 locations
View Trial Details

Related conditions